Based on the results from this study, we recommend to determine the relative expression of RAC1B and RAC1 in clinical tumor biopsy samples, i.e., by immunohistochemistry, and evaluate their diagnostic value for assessing molecular subtype or predicting invasive potential. The gene discussed is RAC1; the disease is neoplasm.